TPT-004
N/A
Report date: 2023/11/03 17:02:49
NME
Base Information
Drug NameTPT-004
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeibniz-Forschungsinstitut für Molekulare PharmakologieTrypto Therapeutics GmbHExperimental Pharmacology & Oncology Berlin-Buch GmbH
China Registration ClassN/A
Develop Information
Active CompaniesExperimental Pharmacology & Oncology Berlin-Buch GmbHTrypto Therapeutics GmbHLeibniz-Forschungsinstitut für Molekulare Pharmakologie
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A